HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sclerotherapy of spermatoceles and hydroceles. Long-term results of polidocanol use].

Abstract
Treatment of hydroceles and spermatoceles with evacuation, followed by injection of the sclerosing agent Polidocanol 3% (Aetoxysklerol), is a simple, low cost alternative to surgery. For the patient, it is also less painful compared to sclerotherapy using tetracycline. This article shows that the long term results are very promising. 28 patients, of whom two were treated for bilateral celes, gave us a total of 30 treatments. We interviewed the patients 62 months (52-67 months) after treatment, and found that in 24 of the 30 treatments there were no sign of relapse. In three cases the patient had noticed a small relapse, but had no pain. Three have later been treated with surgery.
AuthorsM Andersen, G Bentsen
JournalTidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke (Tidsskr Nor Laegeforen) Vol. 113 Issue 25 Pg. 3146-7 (Oct 20 1993) ISSN: 0029-2001 [Print] Norway
Vernacular TitleSklerosering av spermatoceler og hydroceler. Langtidsresultater ved bruk av polidocanol.
PMID8273039 (Publication Type: Journal Article)
Chemical References
  • Polidocanol
  • Polyethylene Glycols
Topics
  • Adult
  • Aged
  • Humans
  • Male
  • Middle Aged
  • Polidocanol
  • Polyethylene Glycols (administration & dosage)
  • Prognosis
  • Sclerotherapy
  • Spermatocele (therapy)
  • Testicular Hydrocele (therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: